文献速递精神分裂症与精神病性障碍心境障碍

基于消费者信用报告数据评估精神分裂症或双相I型障碍患者的破坏性生活事件

Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency.
PubMed 文献 · JAMA Psychiatry · 2023-01-01

本研究利用两大综合医疗系统的电子健康记录数据,将2007至2019年诊断的双相I型障碍或精神分裂症患者与抑郁症患者及一般健康人群按1:1匹配,并链接消费者信用报告机构聚合的公共记录数据(匹配率98%)。结果显示双相I型障碍患者地址变更和财务事件风险更高,而精神分裂症患者被捕风险与一般健康人群差异最大(OR 3.04)。

要点

  • 双相I型障碍患者地址变更发生率比一般健康人群高(最高发生率比1.25)。
  • 双相I型障碍患者经历财务破坏性事件的比值比为1.15至1.50。
  • 精神分裂症和双相I型障碍患者被捕风险均显著高于一般健康人群(OR分别为3.04和3.27)。

核心结论

  • 消费者信用报告机构聚合的数据可用于支持双相I型障碍或精神分裂症患者破坏性生活事件的人群水平研究。

研究设计与样本

  • 研究使用Kaiser Permanente南加州和Henry Ford Health两个大型综合医疗系统的电子健康记录数据,纳入2007至2019年诊断的双相I型障碍或精神分裂症患者。
  • 患者按年龄、诊断年龄、性别、种族和民族以及医疗补助状态1:1匹配至抑郁症对照组和一般健康对照组,并与消费者信用报告机构聚合的公共记录数据链接(匹配率98%)。

主要发现

  • 双相I型障碍患者地址变更比一般健康人群更常见(发生率比最高达1.25,95%CI 1.23-1.28)。
  • 双相I型障碍患者经历任何财务破坏性事件的比值比为1.15(95%CI 1.07-1.24)至1.50(95%CI 1.42-1.58)。
  • 与一般健康人群相比,被捕的差异最大:双相I型障碍OR 3.27(95%CI 2.84-3.78),精神分裂症OR 3.04(95%CI 2.57-3.59)。
  • 精神分裂症患者地址变更和财务事件均少于其匹配对照组。

临床怎么用

  • 临床可关注双相I型障碍患者的地址变更和财务事件风险,以及精神分裂症和双相I型障碍患者的被捕风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: There is a dearth of population-level data on major disruptive life events (defined here as arrests by a legal authority, address changes, bankruptcy, lien, and judgment filings) for patients with bipolar I disorder (BPI) or schizophrenia, which has limited studies on mental health and treatment outcomes. OBJECTIVE: To conduct a population-level study on disruptive life events by using publicly available data on disruptive life events, aggregated by a consumer credit reporting agency in conjunction with electronic health record (EHR) data. DESIGN, SETTING, AND PARTICIPANTS: This study used EHR data from 2 large, integrated health care systems, Kaiser Permanente Southern California and Henry Ford Health. Cohorts of patients diagnosed from 2007 to 2019 with BPI or schizophrenia were matched 1:1 by age at analysis, age at diagnosis (if applicable), sex, race and ethnicity, and Medicaid status to (1) an active comparison group with diagnoses of major depressive disorder (MDD) and (2) a general health (GH) cohort without diagnoses of BPI, schizophrenia, or MDD. Patients with diagnoses of BPI or schizophrenia and their respective comparison cohorts were matched to public records data aggregated by a consumer credit reporting agency (98% match rate). Analysis took place between November 2020 and December 2022. MAIN OUTCOMES AND MEASURES: The differences in the occurrence of disruptive life events among patients with BPI or schizophrenia and their comparison groups. RESULTS: Of 46 167 patients, 30 008 (65%) had BPI (mean [SD] age, 42.6 [14.2] years) and 16 159 (35%) had schizophrenia (mean [SD], 41.4 [15.1] years). The majoriy of patients were White (30 167 [65%]). In addition, 18 500 patients with BPI (62%) and 6552 patients with schizophrenia (41%) were female. Patients with BPI were more likely to change addresses than patients in either comparison cohort (with the incidence ratio being as high as 1.25 [95% CI, 1.23-1.28]) when compared with GH cohort. Patients with BPI were also more likely to experience any of the financial disruptive life events with odds ratio ranging from 1.15 [95% CI, 1.07-1.24] to 1.50 [95% CI, 1.42-1.58]). The largest differences in disruptive life events were seen in arrests of patients with either BPI or schizophrenia compared with GH peers (3.27 [95% CI, 2.84-3.78] and 3.04 [95% CI, 2.57-3.59], respectively). Patients with schizophrenia had fewer address changes and were less likely to experience a financial event than their matched comparison cohorts. CONCLUSIONS AND RELEVANCE: This study demonstrated that data aggregated by a consumer credit reporting agency can support population-level studies on disruptive life events among patients with BPI or schizophrenia.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Nau CL, Braciszewski JM, Rossom RC, et al. Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency. JAMA Psychiatry. 2023. PMID: 37163288. doi:10.1001/jamapsychiatry.2023.1179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。